Pharmacokinetics and Safety of Nelfinavir When Used in Combination with Zidovudine and Lamivudine in HIV-Infected Pregnant Women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353

BACKGROUND: Combination antiretroviral regimens including nelfinavir (NFV) are commonly used in pregnancy. We studied the safety, antiviral effect, and pharmacokinetics of NFV and its M8 metabolite with two dosing regimens in combination with zidovudine (ZDV) and lamivudine (3TC) in HIV-infected pre...

詳細記述

保存先:
書誌詳細
主要な著者: Bryson, Y.J., Mirochnick, M., Stek, A., Mofenson, L.M., Connor, J., Capparelli, E., Watts, D.H., Huang, S., Hughes, M.D., Kaiser, K., Purdue, L., Asfaw, Y., Keller, M., Smith, E.
フォーマット: Artigo
言語:Inglês
出版事項: 2008
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4043374/
https://ncbi.nlm.nih.gov/pubmed/18474496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hct0902-115
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料